Table 5.
Main outcomes analyzed by hospital.
| Hospital | Pre-COVID 2019 | During COVID 2020 | P value |
|---|---|---|---|
| Valley Children's | |||
| Perforated appendicitis, n (%) | 181/406 (44.6) | 203/433 (46.9) | 0.50 |
| Duration of symptoms, days: median (IQR) | 2 (1-3) | 2 (1-3) | 0.82 |
| Non-operative management, n (%) | 33/406 (8.1) | 74/433 (17.1) | 0.0001 |
| UC Davis | |||
| Perforated appendicitis, n (%) | 43/104 (41.4) | 36/99 (36.4) | 0.47 |
| Duration of symptoms, days: median (IQR) | 2 (1-3) | 2 (1-3) | 0.18 |
| Non-operative management, n (%) | 5/104 (4.8) | 10/99 (10.1) | 0.18 |
| UCLA | |||
| Perforated appendicitis, n (%) | 14/63 (22.2) | 7/33 (21.2) | 1.00 |
| Duration of symptoms, days: median (IQR) | 2 (1-2) | 1 (1-2) | 0.11 |
| Non-operative management, n (%) | 8/63 (12.7) | 7/33 (21.2) | 0.38 |
| Harbor-UCLA | |||
| Perforated appendicitis, n (%) | 7/33 (21.2) | 3/24 (12.5) | 0.49 |
| Duration of symptoms, days: median (IQR) | 2 (1-3) | 1 (1-2) | 0.05 |
| Non-operative management, n (%) | 7/33 (21.2) | 2/24 (8.3) | 0.28 |